Literature DB >> 714325

Relaxing effects of Nifedipine on the nonpregnant human uterus in vitro and in vivo.

U Ulmsten, K E Andersson, A Forman.   

Abstract

The effects of the calcium antagonist Nifedipine were investigated on isolated human myometrium and on uterine activity in healthy women during their first menstrual days. Nifedipine (0.01-1.0 microgram/ml) had a concentration-related inhibiting effect on spontaneous activity of the myometrial strips, and relaxed preparations contracted by potassium. In vivo, Nifedipine (20-30 mg) given orally, effectively and rapidly reduced uterine activity, decreasing both amplitude and frequency of uterine contractions, and reduced basal tone. A moderate increase in heart rate and a transient facial flushing were noted, but otherwise no side effects were observed. Calcium antagonists like Nifedipine represent a new approach to the problem of relaxing the myometrium, and might be an interesting therapeutic alternative in situations where inhibition of unwanted uterine activity is desirable.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 714325

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  11 in total

Review 1.  Pharmacokinetics of tocolytic agents.

Authors:  Vassilis Tsatsaris; Dominique Cabrol; Bruno Carbonne
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

Review 2.  Hormonal signaling and signal pathway crosstalk in the control of myometrial calcium dynamics.

Authors:  Barbara M Sanborn
Journal:  Semin Cell Dev Biol       Date:  2007-05-18       Impact factor: 7.727

Review 3.  Nifedipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in ischaemic heart disease, hypertension and related cardiovascular disorders.

Authors:  E M Sorkin; S P Clissold; R N Brogden
Journal:  Drugs       Date:  1985-09       Impact factor: 9.546

Review 4.  Treatment of dysmenorrhoea and premenstrual syndrome with non-steroidal anti-inflammatory drugs.

Authors:  S S Shapiro
Journal:  Drugs       Date:  1988-10       Impact factor: 9.546

5.  Trial of the calcium antagonist nifedipine in the treatment of primary dysmenorrhoea.

Authors:  B Sandahl; U Ulmsten; K E Andersson
Journal:  Arch Gynecol       Date:  1979-08

6.  Some observations on the effects of a calcium channel blocker, nitrendipine, in early human pregnancy.

Authors:  M R Lawrence; F Broughton Pipkin
Journal:  Br J Clin Pharmacol       Date:  1987-06       Impact factor: 4.335

7.  Differential effects of the calcium-antagonistic vasodilators, nifedipine and verapamil, on the tracheal musculature and vasculature of the dog.

Authors:  N Himori; N Taira
Journal:  Br J Pharmacol       Date:  1980-04       Impact factor: 8.739

8.  Treatment of premature labor with the calcium antagonist nifedipine.

Authors:  U Ulmsten; K E Andersson; L Wingerup
Journal:  Arch Gynecol       Date:  1980-01

9.  Efficacy of nifedipine in the treatment of angina pectoris and chronic airways obstruction.

Authors:  S S Jaiprakash; J N Sahay; S S Chatterjee; G MacDonald
Journal:  Postgrad Med J       Date:  1980-09       Impact factor: 2.401

10.  Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist.

Authors:  U Ulmsten
Journal:  Arch Gynecol       Date:  1984
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.